Drug Profile
Zika virus vaccine - Novavax
Alternative Names: ZIKV EnvD VaccineLatest Information Update: 26 Sep 2023
Price :
$50
*
At a glance
- Originator Novavax
- Developer Harvard Medical School; Novavax
- Class Synthetic vaccines; Zika virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Zika virus infection
Most Recent Events
- 26 Sep 2023 Discontinued - Preclinical for Zika virus infection (Prevention) in USA (unspecified route)
- 28 Dec 2020 No recent reports of development identified for preclinical development in Zika-virus-infection(Prevention) in USA
- 09 Nov 2016 Novavax plans a phase I trial for Zika virus infection (Prevention) in USA